Year: 2016
Type: dissertation
Abstract: Chronic diseases: definition and burdenChronic diseases are defined as diseases of long duration and generally slow progression (WHO, 2005a).Chronic diseases are commonly used as a synonym for non-communicable diseases, denoting diseases that are not passed from one person to another.However, some communicable diseases (i.e.infectious diseases) can be chronic too, for example HIV infection.In this PhD-thesis, chronic diseases will be defined as Chronic Non-Communicable Diseases (CNCDs).The World Health Organization (WHO) addresses four major CNCDs, considered to have the highest share in CNCD morbidity and mortality 1 , namely cardiovascular disease (mainly coronary heart disease and stroke), cancer, chronic respiratory diseases (such as chronic obstructive pulmonary disease, asthma, pulmonary hypertension) and diabetes (WHO, 2014a).Mental disorders, such as depression or anxiety disorders, are generally not included in the concept of CNCDs, although these disorders have a large impact on society as well, in terms of population health and public expenditure (Lokkerbol et al., 2013).The disease burden associated with mental disorders is largely attributable to disability rather than mortality (Figure 1).In Belgium, 20% of the population uses psychotropic drugs (Van Herck & Van de Cloot, 2013).Besides, although not directly related to mortality, mental disorders, particularly depression and schizophrenia, are the major determinant of suicide (Ferrari et al., 2014;Harris & Barraclough, 1998; WHO, 2004).Half of the people with suicidal thoughts suffer from a mental disorder (Nock et al., 2009).Because of their high burden, some health scientists argue for mental disorders to be classified as one of the main types of CNCDs (Ivbijaro, 2011;Ngo et al., 2013).Therefore, in this PhD-thesis, the concept of CNCDs also includes mental disorders, unless otherwise stated.CNCDs are major contributors to the global burden of disease (Vos et al., 2015; WHO, 2014a).The burden of disease concept can be described as the impact of a health problem on an individual or a population usually measured by mortality and morbidity (called health burden) or the financial impact (called economic burden). Health burdenMany measures are available to assess the health of a population, such as disease prevalence, disease incidence, mortality, life-expectancy, etc. Summary measures of population health are measures that combine information on mortality and morbidity to represent the health of a particular population into one single number (Field & Gold, 1998).A wide array of summary measures have been proposed, for example disability-free life expectancy, disability-adjusted life expectancy, health-adjusted life expectancy, or disability-adjusted life years (Murray, Salomon, & Mathers, 2000).The WHO measures the global health burden using the summary measure of disability-adjusted life year (DALY) 2 .The European burden of disease in 2012 consisted of 314,387,085 DALYs, or 348 DALYs per 1,000 people, 1 Morbidity data indicate the number of persons in a population who become ill (incidence) or are ill at a given time (prevalence) (Centers for Disease Control and Prevention, 2016b) Mortality data indicate numbers of deaths by place, time or cause (WHO, 2016c) 2 DALYs are calculated as the sum of years of life lost due to early mortality and years lived with disability due to the disease or its consequences.As such, the DALY concept includes life-expectancy, disease incidence/prevalence, disability weight and average duration of the condition until death. * portion not specifiedPrevalence of risk factors being worse in Belgium compared to the European average are shown in bold Source: (Eurobarometer, 2014; Eurostat, 2008b) Early detection Although the incidence of cancer might be reduced by identifying and modifying the main modifiable behaviours, these strategies cannot eliminate the majority of yet prevalent and irreversible but undetected cancers which are sometimes only diagnosed in late stages.Therefore, early detection, i.e. detection of a pre-cancerous or a cancerous lesion prior to the appearance of symptoms, could prevent disease progression and the associated health and economic consequences and thus is also a New New Current Current Cost of intervention Other medical costs Total Cost + Costs due to productivity loss New
Authors: Lore Pil, Lieven Annemans, Koen Putman
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Keywords: non-communicable diseases, health economic evaluation, chronic disease prevention, disease burden, economic burden, mental illness, depression, schizophrenia, suicide, cardiovascular disease, cancer, chronic respiratory disease, diabetes mellitus, health care costs, health care utilization, health care access
Open Access status: green
OpenAlex ID: W2608077515
